December 13, 2018 6:46pm

Uncertainty surrounded the sector as Biogen (BIIB) backed-out of collaboration; the question is who the next company to be “dumped” is for not showing signs of clinical activity?

Stocks traded with low volume


Out and about: Pre-open indications: 2 HITs


Investors should be reading about today’s final “figures” – be a subscriber and be ready for tomorrow’s session! As I have stated … today’s gold could be tomorrow’s tin!


Members only. Please login.